Time-limited association between plasma transfusion and mortality in pediatric traumatic brain injury

Leah Furman1, Erin V Feeney, Barbara A Gaines

  • 1From the Department of Surgery (L.F., E.V.F.), University of Pittsburgh Medical Center; Trauma and Transfusion Medicine Research Center (L.F., E.V.F., C.M.L.), University of Pittsburgh, Pittsburgh, Pennsylvania; Division of Pediatric Surgery, Department of Surgery (B.A.G.), University of Texas Southwestern Medical Center, Dallas, Texas; and Department of Surgery and Critical Care Medicine (C.M.L.), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Insights

Early plasma transfusion in children with severe traumatic brain injury (TBI) was associated with a reduced risk of death within 4 hours. This survival benefit did not extend beyond 24 hours, suggesting a critical window for intervention.

Area of Science:

  • Pediatric critical care
  • Trauma surgery
  • Emergency medicine

Background:

  • Traumatic brain injury (TBI) is a leading cause of death in children.
  • Prehospital plasma transfusion in adults with TBI is linked to lower mortality.
  • The effect of early plasma administration on pediatric TBI outcomes is not well understood.

Purpose of the Study:

  • To investigate the impact of early plasma transfusion on mortality in children with severe TBI.
  • To determine if early plasma administration affects 4-hour, 24-hour, and 30-day mortality rates.
  • To evaluate the association between plasma resuscitation and survival in pediatric severe TBI.

Main Methods:

  • Retrospective cohort study using the National Trauma Data Bank (2020-2022).
  • Included children aged 1-17 years with severe TBI (head AIS scores 4-5).
  • Analyzed plasma transfusion within 4 hours of arrival using Cox proportional hazard models, adjusting for multiple clinical factors.

Main Results:

  • 1,594 (10.9%) of 14,691 eligible children received early plasma.
  • Early plasma administration was associated with a significantly lower risk of 4-hour mortality (HR=0.610, p=0.005).
  • This association with reduced mortality did not persist at 24 hours (HR=0.894) or 30 days (HR=1.132).

Conclusions:

  • Early plasma transfusion in pediatric severe TBI is linked to a significant reduction in 4-hour mortality.
  • The survival benefit of early plasma appears limited to the initial 4-hour period.
  • Further prospective research is necessary to confirm these findings and guide clinical practice.
Abstract